Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19
This study may lead to the identification of additional investigations that can monitor for
signs of disease progression in active surveillance protocols. This can directly benefit
patients by providing them with greater confidence that their disease is being accurately
monitored. In addition, this study may be beneficial to the general management of prostate
cancers by adding to our knowledge of these investigations characterizing prostate cancers.
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening
Primary objective to determine if we can accrue patients to this study in a timely manner.
Nawaid Usmani, MD, FRCPC
Cross Cancer Institute
Canada: Health Canada